Exit interview: Stephen Ubl moves on from AdvaMed

Exit interview: Stephen Ubl moves on from AdvaMed
DeviceTalks Podcast Network
Exit interview: Stephen Ubl moves on from AdvaMed

Oct 15 2015 | 00:25:55

/
Episode • October 15, 2015 • 00:25:55

Hosted By

Kayleen Brown Tom Salemi

Show Notes

Before Stephen Ubl departed for a job as the chief lobbyist for the pharmaceutical industry, medtech's main man in Washington D.C. sat down with us to reflect on his time as CEO of AdvaMed. In this episode of DeviceTalks, we go deep into Ubl's background, the fights over the medical device tax, forging a new partnership with the FDA and more.

Previous Episode

Marie Johnson and the mission to prevent sudden heart attacks

Next Episode

Building the Cologuard and the fight against colorectal cancer with Exact Sciences Graham Lidgard

Other Episodes

May 23, 2025

How MedTechVets helps veterans discover new mission, familiar purpose in the MedTech industry

In this episode, Host Tom Salemi interviews Steve Mapa, a former MedTech leader who is now president and executive director of MedTechVets. In this...

Play

01:04:07

February 11, 2022

Diabetes Overview – Checking on promising tools from Dexcom, Bigfoot Biomedical and Senseonics

This week we’ll focus on a few of the exciting companies in the diabetes space. Associate Editor Sean Whooley first tracks down Dexcom CEO...

Play

01:16:06

July 29, 2022

Ethicon’s Tom O’Brien explains the design – and critical need for - its new surgical stapler

In this episode, Tom O’Brien, Ethicon’s worldwide president of endomechanical, gives a detailed lesson on the design of its Echelon 3000 surgical stapler, from...

Play

00:48:13